Hi-Tech Pharmaceuticals, Inc. v. Federal Trade Commission

Issue: (1) Whether a fundamental change in decisional law can independently support relief from a judgment under Federal Rule of Civil Procedure 60(b)(6); and (2) whether the Federal Trade Commission can obtain compensatory equitable remedies as sanctions for civil contempt of a permanent injunction under Section 13(b) of the Federal Trade Commission Act when those remedies are not directly available under Section 13(b).